about
Seeing the unseen--bioturbation in 4D: tracing bioirrigation in marine sediment using positron emission tomography and computed tomographyThe use of radiocobalt as a label improves imaging of EGFR using DOTA-conjugated Affibody molecule.Evaluation of somatostatin and nucleolin receptors for therapeutic delivery in non-small cell lung cancer stem cells applying the somatostatin-analog DOTATATE and the nucleolin-targeting aptamer AS1411.Highly Effective Auger-Electron Therapy in an Orthotopic Glioblastoma Xenograft Model using Convection-Enhanced DeliveryEvaluation of cobalt-labeled octreotide analogs for molecular imaging and auger electron-based radionuclide therapy.High Contrast PET Imaging of GRPR Expression in Prostate Cancer Using Cobalt-Labeled Bombesin Antagonist RM26.Production of the Auger emitter 119Sb for targeted radionuclide therapy using a small PET-cyclotron.A PSMA Ligand Labeled with Cobalt-55 for PET Imaging of Prostate Cancer.In Vivo Evaluation of a Bombesin Analogue Labeled with Ga-68 and Co-55/57.Estimation of Tumor Volumes by 11C-MeAIB and 18F-FDG PET in an Orthotopic Glioblastoma Rat Model.PET imaging with the non-pure positron emitters: (55)Co, (86)Y and (124)I.Chelation, formulation, encapsulation, retention, and in vivo biodistribution of hydrophobic nanoparticles labelled with Co-porphyrin: Oleylamine ensures stable chelation of cobalt in nanoparticles that accumulate in tumorsNovel radioisotope-based nanomedical approachesMultiphonon vibrations at high angular momentum in 182 OsMedium to large scale radioisotope production for targeted radiotherapy using a small PET cyclotronA new and simple calibration-independent method for measuring the beam energy of a cyclotronDesign, Synthesis, Computational, and Preclinical Evaluation of natTi/45Ti-Labeled Urea-Based Glutamate PSMA LigandImproving Contrast and Detectability: Imaging with [55Co]Co-DOTATATE in Comparison with [64Cu]Cu-DOTATATE and [68Ga]Ga-DOTATATESelection of an optimal macrocyclic chelator improves the imaging of prostate cancer using cobalt-labeled GRPR antagonist RM26
P50
Q27310364-6AA47798-D716-4988-A028-B3D87C538D8CQ33920975-DEEFEBE4-B60E-49C4-B5E3-73417D3B8720Q36380909-2085DCFC-B8BA-44A7-921A-369FED462087Q37469883-EF6D4242-AEC7-4981-BC57-7002B69939CBQ38990204-0E3CB70E-42BD-4537-9F7E-D785EAE97E2CQ43216601-26B8B668-6952-4922-8E40-63D00317FF35Q47248084-BF24D39D-984A-4A62-A28F-007AEA7AD904Q47963642-95BEA57B-8A01-4123-A128-CEF13549D2E9Q48105870-CECB8290-A4BE-4700-9EDD-946D099EA694Q50873729-FE46A868-7F14-47D5-BBF0-B6CB0324B90BQ50934349-E7B19264-1E61-44C1-9577-985AA7149FDEQ57037900-A286793C-F1F0-4D6A-87AD-8D7D7C93517FQ60297975-1DB04FC2-830B-4800-8ECC-7B5DB5871DF3Q79282297-D9FA0F11-F5C2-4837-8BD1-C63118FF2C71Q84773262-9495EFF0-9597-49F9-A017-208D89B05E7EQ85166767-3D4EF10C-3930-42C1-BEE0-7DF7A10143E8Q90047175-42D51B61-ABA1-4533-B126-0F43829D4A3CQ90100199-1D16FBEF-3582-47FC-AF97-F5303ECB01E3Q91345029-0AD3615E-3633-4B12-8767-7836DE21D11D
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Helge Thisgaard
@ast
Helge Thisgaard
@en
Helge Thisgaard
@es
Helge Thisgaard
@nl
Helge Thisgaard
@sl
type
label
Helge Thisgaard
@ast
Helge Thisgaard
@en
Helge Thisgaard
@es
Helge Thisgaard
@nl
Helge Thisgaard
@sl
prefLabel
Helge Thisgaard
@ast
Helge Thisgaard
@en
Helge Thisgaard
@es
Helge Thisgaard
@nl
Helge Thisgaard
@sl
P108
P106
P31
P496
0000-0001-9492-448X